David Lebowitz's Stock Ratings

Citigroup Analyst

David Lebowitz is an analyst at Citigroup. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 08/01/2024

Overall Average Return

-1.46%

Smart Score

50.7%

Overall Average Return Percentile

32nd

Number of Ratings

60
Buy NowGet Alert
07/31/2024INCYBuy Now
Incyte
$65.0735.24%$80 → $88MaintainsBuyGet Alert
06/18/2024MIRMBuy Now
Mirum Pharmaceuticals
$40.5557.83%$38 → $64MaintainsBuyGet Alert
05/21/2024PTCTBuy Now
PTC Therapeutics
$33.75-22.96%$18 → $26MaintainsSellGet Alert
05/10/2024NTLABuy Now
Intellia Therapeutics
$26.409.85%$31 → $29MaintainsNeutralGet Alert
05/07/2024PLRXBuy Now
Pliant Therapeutics
$14.31207.48%$45 → $44MaintainsBuyGet Alert
05/03/2024BPMCBuy Now
Blueprint Medicines
$108.30-29.82%$65 → $76MaintainsSellGet Alert
05/02/2024SDGRBuy Now
Schrodinger
$23.5057.45%$39 → $37MaintainsBuyGet Alert
03/06/2024MDGLBuy Now
Madrigal Pharmaceuticals
$284.6634.2% → $382Initiates → BuyGet Alert
03/01/2024SDGRBuy Now
Schrodinger
$23.5065.96%$47 → $39MaintainsBuyGet Alert
02/29/2024SDGRBuy Now
Schrodinger
$23.5065.96%$47 → $39MaintainsBuyGet Alert
02/26/2024COGTBuy Now
Cogent Biosciences
$9.4337.86%$11 → $13MaintainsBuyGet Alert
02/23/2024BBIOBuy Now
BridgeBio Pharma
$26.0576.58%$42 → $46MaintainsBuyGet Alert
02/16/2024BPMCBuy Now
Blueprint Medicines
$108.30-39.98%$54 → $65MaintainsSellGet Alert
02/14/2024INCYBuy Now
Incyte
$65.0724.48%$82 → $81MaintainsBuyGet Alert
02/08/2024ASNDBuy Now
Ascendis Pharma
$133.5036.33%$146 → $182MaintainsBuyGet Alert
02/08/2024COGTBuy Now
Cogent Biosciences
$9.4316.65% → $11Initiates → BuyGet Alert
12/15/2023EXELBuy Now
Exelixis
$23.4532.2% → $31Initiates → BuyGet Alert
11/07/2023BBIOBuy Now
BridgeBio Pharma
$26.0561.23% → $42Initiates → BuyGet Alert
07/31/2023IONSBuy Now
Ionis Pharmaceuticals
$49.4621.31%$36 → $60UpgradeNeutral → BuyGet Alert
07/25/2023INCYBuy Now
Incyte
$65.0726.02% → $82Initiates → BuyGet Alert
06/30/2023BMRNBuy Now
Biomarin Pharmaceutical
$84.3313.84%$103 → $96MaintainsNeutralGet Alert
05/08/2023SDGRBuy Now
Schrodinger
$23.50112.77%$52 → $50MaintainsBuyGet Alert
05/04/2023IONSBuy Now
Ionis Pharmaceuticals
$49.46-27.21%$30 → $36UpgradeSell → NeutralGet Alert
04/27/2023BMRNBuy Now
Biomarin Pharmaceutical
$84.3322.14%$114 → $103MaintainsNeutralGet Alert
04/05/2023ASNDBuy Now
Ascendis Pharma
$133.509.36%$163 → $146MaintainsBuyGet Alert
03/13/2023PLRXBuy Now
Pliant Therapeutics
$14.31249.41%$55 → $50MaintainsBuyGet Alert
02/21/2023BMRNBuy Now
Biomarin Pharmaceutical
$84.3337.55% → $116Initiates → NeutralGet Alert
01/31/2023SDGRBuy Now
Schrodinger
$23.50117.02%$48 → $51MaintainsBuyGet Alert
01/24/2023NTLABuy Now
Intellia Therapeutics
$26.4047.73%$48 → $39UpgradeSell → NeutralGet Alert
01/24/2023PLRXBuy Now
Pliant Therapeutics
$14.31284.35%$36 → $55MaintainsBuyGet Alert
11/10/2022MIRMBuy Now
Mirum Pharmaceuticals
$40.55-16.15%$38 → $34MaintainsBuyGet Alert
11/10/2022IONSBuy Now
Ionis Pharmaceuticals
$49.46-37.32%$28 → $31MaintainsSellGet Alert
11/03/2022ASNDBuy Now
Ascendis Pharma
$133.5022.1%$157 → $163MaintainsBuyGet Alert
09/01/2022MIRMBuy Now
Mirum Pharmaceuticals
$40.55-6.29% → $38Initiates → BuyGet Alert
09/01/2022PTCTBuy Now
PTC Therapeutics
$33.75107.41% → $70Initiates → BuyGet Alert
09/01/2022NTLABuy Now
Intellia Therapeutics
$26.4089.39% → $50Initiates → SellGet Alert
09/01/2022PLRXBuy Now
Pliant Therapeutics
$14.31151.57% → $36Initiates → BuyGet Alert
08/10/2022IONSBuy Now
Ionis Pharmaceuticals
$49.46-43.39%$26 → $28MaintainsSellGet Alert
07/15/2022IMRXBuy Now
Immuneering
$1.66622.89%$18 → $12MaintainsEqual-WeightGet Alert
07/15/2022ALNYBuy Now
Alnylam Pharmaceuticals
$237.46-30.94%$170 → $164MaintainsEqual-WeightGet Alert
06/10/2022BPMCBuy Now
Blueprint Medicines
$108.30-62.14%$68 → $41DowngradeNeutral → SellGet Alert
06/07/2022ARQTBuy Now
Arcutis Biotherapeutics
$10.49271.78%$36 → $39MaintainsOverweightGet Alert
05/12/2022ASNDBuy Now
Ascendis Pharma
$133.5018.35%$187 → $158MaintainsBuyGet Alert
05/10/2022ARQTBuy Now
Arcutis Biotherapeutics
$10.49243.18%$37 → $36MaintainsOverweightGet Alert
05/09/2022IONSBuy Now
Ionis Pharmaceuticals
$49.46-39.34%$31 → $30MaintainsUnderweightGet Alert
04/29/2022ALNYBuy Now
Alnylam Pharmaceuticals
$237.46-11.14%$223 → $211MaintainsBuyGet Alert
04/13/2022BPMCBuy Now
Blueprint Medicines
$108.30-37.21%$71 → $68MaintainsNeutralGet Alert
03/15/2022ASNDBuy Now
Ascendis Pharma
$133.5047.57%$180 → $197MaintainsOverweightGet Alert
03/07/2022ASNDBuy Now
Ascendis Pharma
$133.5034.83%$197 → $180MaintainsOverweightGet Alert
03/02/2022ARQTBuy Now
Arcutis Biotherapeutics
$10.49252.72%$35 → $37MaintainsOverweightGet Alert
03/01/2022ALNYBuy Now
Alnylam Pharmaceuticals
$237.46-6.09% → $223Initiates → BuyGet Alert
03/01/2022SDGRBuy Now
Schrodinger
$23.50134.04% → $55Initiates → BuyGet Alert
03/01/2022IONSBuy Now
Ionis Pharmaceuticals
$49.46-47.43% → $26Initiates → SellGet Alert
03/01/2022BPMCBuy Now
Blueprint Medicines
$108.30——Initiates → NeutralGet Alert
03/01/2022ASNDBuy Now
Ascendis Pharma
$133.5040.07% → $187Initiates → BuyGet Alert
02/23/2022ALNYBuy Now
Alnylam Pharmaceuticals
$237.46-11.56%$215 → $210MaintainsOverweightGet Alert
01/18/2022ALNYBuy Now
Alnylam Pharmaceuticals
$237.46-9.46%$226 → $215MaintainsOverweightGet Alert
11/19/2021ARQTBuy Now
Arcutis Biotherapeutics
$10.49233.65%—MaintainsOverweightGet Alert
10/12/2021AVROBuy Now
Avrobio
——$324 → $300MaintainsOverweightGet Alert
07/16/2021AVROBuy Now
Avrobio
——$372 → $348MaintainsOverweightGet Alert